- Home
- CGTX vs CXAI Comparison
CGTX vs CXAI Comparison
Compare CGTX & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- CXAI
- Stock Information
- Founded
- CGTX 2007
- CXAI N/A
- Country
- CGTX United States
- CXAI United States
- Employees
- CGTX N/A
- CXAI N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- CXAI EDP Services
- Sector
- CGTX Health Care
- CXAI Technology
- Exchange
- CGTX Nasdaq
- CXAI Nasdaq
- Market Cap
- CGTX 23.1M
- CXAI 22.4M
- IPO Year
- CGTX 2021
- CXAI N/A
- Fundamental
- Price
- CGTX $0.31
- CXAI $1.10
- Analyst Decision
- CGTX Strong Buy
- CXAI
- Analyst Count
- CGTX 5
- CXAI 0
- Target Price
- CGTX $6.13
- CXAI N/A
- AVG Volume (30 Days)
- CGTX 692.0K
- CXAI 574.5K
- Earning Date
- CGTX 05-07-2025
- CXAI 05-20-2025
- Dividend Yield
- CGTX N/A
- CXAI N/A
- EPS Growth
- CGTX N/A
- CXAI N/A
- EPS
- CGTX N/A
- CXAI N/A
- Revenue
- CGTX N/A
- CXAI $7,142,000.00
- Revenue This Year
- CGTX N/A
- CXAI $28.54
- Revenue Next Year
- CGTX N/A
- CXAI $66.67
- P/E Ratio
- CGTX N/A
- CXAI N/A
- Revenue Growth
- CGTX N/A
- CXAI N/A
- 52 Week Low
- CGTX $0.31
- CXAI $0.76
- 52 Week High
- CGTX $2.95
- CXAI $3.82
- Technical
- Relative Strength Index (RSI)
- CGTX 31.37
- CXAI 50.42
- Support Level
- CGTX $0.40
- CXAI $1.04
- Resistance Level
- CGTX $0.47
- CXAI $1.21
- Average True Range (ATR)
- CGTX 0.03
- CXAI 0.06
- MACD
- CGTX -0.01
- CXAI -0.00
- Stochastic Oscillator
- CGTX 2.76
- CXAI 44.44
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.